JPWO2024100756A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2024100756A5
JPWO2024100756A5 JP2023538945A JP2023538945A JPWO2024100756A5 JP WO2024100756 A5 JPWO2024100756 A5 JP WO2024100756A5 JP 2023538945 A JP2023538945 A JP 2023538945A JP 2023538945 A JP2023538945 A JP 2023538945A JP WO2024100756 A5 JPWO2024100756 A5 JP WO2024100756A5
Authority
JP
Japan
Prior art keywords
ovaries
uterus
agent according
fallopian tubes
preventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023538945A
Other languages
English (en)
Japanese (ja)
Other versions
JP7401156B1 (ja
JPWO2024100756A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/041509 external-priority patent/WO2024100756A1/ja
Application granted granted Critical
Publication of JP7401156B1 publication Critical patent/JP7401156B1/ja
Publication of JPWO2024100756A1 publication Critical patent/JPWO2024100756A1/ja
Publication of JPWO2024100756A5 publication Critical patent/JPWO2024100756A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023538945A 2022-11-08 2022-11-08 子宮、卵管および卵巣における炎症の予防および／または治療剤 Active JP7401156B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/041509 WO2024100756A1 (ja) 2022-11-08 2022-11-08 子宮、卵管および卵巣における炎症の予防および／または治療剤

Publications (3)

Publication Number Publication Date
JP7401156B1 JP7401156B1 (ja) 2023-12-19
JPWO2024100756A1 JPWO2024100756A1 (https=) 2024-05-16
JPWO2024100756A5 true JPWO2024100756A5 (https=) 2024-10-09

Family

ID=89190282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023538945A Active JP7401156B1 (ja) 2022-11-08 2022-11-08 子宮、卵管および卵巣における炎症の予防および／または治療剤

Country Status (2)

Country Link
JP (1) JP7401156B1 (https=)
WO (1) WO2024100756A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08252088A (ja) * 1995-03-17 1996-10-01 Nippo Kagaku Kk クロストリジウム属細菌の培養方法
EP2005841A4 (en) * 2006-03-31 2009-09-30 Nippon Paper Chemicals Co Ltd COMPOSITION FOR BEVERAGE OR FOOD
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
KR102646764B1 (ko) 2017-01-27 2024-03-13 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 질환 및 장애의 치료 및 방지를 위한 단쇄 지방산의 용도
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
CA3102404A1 (en) 2018-06-05 2019-12-12 Flagship Pioneering Innovations V, Inc. Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease

Similar Documents

Publication Publication Date Title
Phan et al. Ginger extract components suppress induction of chemokine expression in human synoviocytes
PT1175214E (pt) Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
CN105263504A (zh) 用于预防和/或治愈细菌性阴道病的包含乳酸菌的组合物
US12005085B2 (en) Probiotic method and composition for maintaining a healthy vaginal microbiome
CA2319201A1 (en) Celecoxib compositions
JP2022188083A5 (https=)
EP1959988B2 (en) Use of bovine lactoferrin for treating destructive inflammation of mucous membrane
CA3124725A1 (en) Methods of treatment of inflammatory conditions and associated infections
MY128366A (en) Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
CN115607577A (zh) 一种具有缓解口腔炎症功效的益生菌剂及其制备方法和应用
O'Riordain et al. Dosage and timing of anti-TNF-α antibody treatment determine its effect on resistance to sepsis after injury
JPWO2024100756A5 (https=)
Cazzola et al. Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view
CN105147703B (zh) 黄柏酮在制备防治溃疡性结肠炎的药物中的应用
CA3013734C (en) Method and composition for treatment and prevention of broad spectrum virus ailments
König et al. Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin)
CN105079012B (zh) 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用
KR20230013234A (ko) 병풀 발효 추출물을 유효성분으로 포함하는 호흡기 질환의 예방, 개선 또는 치료용 조성물
CN104983728A (zh) 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用
US10391114B2 (en) Therapeutic combinations of curcuminoids and flavonoids
CN105078960A (zh) 芫花素在制备防治溃疡性结肠炎的药物或食品中的应用
TWI878748B (zh) 乳酸菌組用於預防或治療nsaid引發的胃潰瘍之用途
Das et al. A brief review of muco-protective agent in the treatment of recurrent aphthous ulcer and behcet’s syndrome: Rebamipide
WO2018122762A1 (en) Oral preparation comprising a probiotic preparation of lactobacilluls helveticus
WO2022216852A9 (en) Pharmaceutical compositions for treating diseases